在临床一线工作十余年，积累了丰富的临床经验，熟练掌握常见传染病、多发病的诊治技术。认真负责对待每一位病人，作风踏实，思路缜密。作为主要成员之一，参与多项重大课题（包括传染病防治重大科技专项、国家科技攻关、国家自然科学基金重点项目、863计划等）；参编《临床感染病学》、《人工肝脏》等书籍。主要发表的文章如下：
1. Liu XL, Li LJ, Chen Z. Isolation and primary culture of rat hepatocytes. Hepatobiliary Pancreat Dis Int, 2002, 1:77-79.
2. 刘小丽，李兰娟. SELDI-TOF MS技术及其在传染性疾病研究中的应用. 国外医学∙流行病学传染病学分册. 2005,32:149-152.
3. Li LJ, Liu XL, Xu XW, Sheng GP, Chen Y, Chen YM, Huang JR, Yang Q. Comparison of plasma exchange with different membrane pore sizes in the treatment of severe viral hepatitis. Ther Apher, 2005, 9:396-401.
4. Du WB, Li LJ, Huang JR, Yang Q, Liu XL, Li J, Chen YM, Cao HC, Xu W, Fu SZ, Chen YG. Effects of artificial liver support system on patients with acute or chronic liver failure. Transplant Proc 2005; 37(10):4359-4364
5. Yang J, Zhao X, Liu X, Wang C, Gao P, Wang J, Li L, Gu J, Yang S, Xu G. High performance liquid chromatography-mass spectrometry for metabonomics: potential biomarkers for acute deterioration of liver function in chronic hepatitis B. J Proteome Res, 2006, 5:554-561.
6. Li LJ, Zhang YM, Liu XL. ALSS in China. Ther Apher 2006, 10: 160–167.
7. Liu X, Li L, Zhang G, Sheng G, Xu W. An approach to characterizing serum low molecular weight proteins in liver injury with SELDI-TOF MS and factor analysis. Clin Biochem, 2007, 40: 1266-1271.
8. 刘小丽, 李兰娟, 盛国平, 徐威, 徐亮. 重型肝炎预后相关的低分子量蛋白质谱研究. 中华传染病杂志2007，25： 327-331.
9. Yu K, Sheng G, Sheng J, Chen Y, Xu W, Liu X, Cao H, Qu H, Cheng Y, Li L. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J Proteome Res. 2007, 6:2413-2419
10. 刘小丽, 盛国平, 徐威, 李兰娟. 慢性重型肝炎患者血清中的低分子量蛋白质研究. 中国病理生理杂志. 2008, 24:1794-1798.
11. Zou Y, Ni Y, Liu X(通讯作者), Chen X. Misdiagnosis of Behçet's disease with unknown protracted fever and chill after surgical excision of cardiac tumor. Rheumatol Int. 2012, 32:2177-2179.
